Filter Results:
(4,651)
Show Results For
- All HBS Web
(4,651)
- People (2)
- News (956)
- Research (3,635)
- Events (5)
- Multimedia (3)
- Faculty Publications (2,854)
Show Results For
- All HBS Web
(4,651)
- People (2)
- News (956)
- Research (3,635)
- Events (5)
- Multimedia (3)
- Faculty Publications (2,854)
- January 2018
- Case
Under Armour
By: Rory McDonald, Clayton M. Christensen, Daniel West and Jonathan E. Palmer
After 20 years of growth unprecedented in the sports apparel industry, Under Armour finds itself with a new record to beat: making the leap from $5 to $10 billion in sales—a feat only accomplished to date by competitors Nike and Adidas. At the heart of this challenge... View Details
Keywords: Under Armour; Nike; Adidas; "Jobs To Be Done; Purpose Brands; Entrepreneurship; Customer Focus and Relationships; Innovation Strategy; Business Growth and Maturation; Growth Management; Innovation Leadership; Apparel and Accessories Industry; Apparel and Accessories Industry; Apparel and Accessories Industry; Apparel and Accessories Industry; Apparel and Accessories Industry; Apparel and Accessories Industry; United States; Maryland; Baltimore
McDonald, Rory, Clayton M. Christensen, Daniel West, and Jonathan E. Palmer. "Under Armour." Harvard Business School Case 618-020, January 2018.
- Web
Organizational Behavior - Faculty & Research
to women and work, some of the most ubiquitous beliefs are the most mistaken. More Information 2015 Thinkers50 Innovation Award By: Linda A. Hill Professor Linda Hill won the 2015 Thinkers50 Distinguished... View Details
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- November 2002 (Revised June 2003)
- Case
Corning, Inc.: Technology Strategy in 2003
Corning, Inc. has a 150-year history of building a strategy around innovation. Founded as a glass manufacturer in 1851, the company quickly established itself as a maker of specialty glass products and over the next 100 years diversified into light bulbs, television,... View Details
Keywords: Information Technology; Strategy; Innovation Strategy; Situation or Environment; Research and Development; Consumer Products Industry; United States
Henderson, Rebecca. "Corning, Inc.: Technology Strategy in 2003." Harvard Business School Case 703-440, November 2002. (Revised June 2003.)
- March 2004 (Revised November 2012)
- Teaching Note
P&G Japan: The SK-II Globalization Project (TN)
Traces changes in P&G's international strategy and structure, culminating in Organization 2005, a reorganization that places strategic emphasis on product innovation rather than geographic expansion and shifts power from local subsidiary to global business management.... View Details
- November 2008 (Revised February 2009)
- Case
Omron: Sensing Society
By: Rosabeth M. Kanter and Ethan S Bernstein
"Leading profitable growth is only part of the goal. We cannot live without breathing, but we do not live in order to take a breath,” said Omron's President and CEO, Hisao Sakuta, in 2008. Omron, a $7B global supplier of sensors, control system components, advanced... View Details
- April 2021 (Revised June 2021)
- Case
IBM: Design Thinking
By: Srikant M. Datar, Amram Migdal and Paul Hamilton
This case describes the 2012-2020 effort at IBM to implement design thinking throughout the company and hire thousands of designers to serve on every product team alongside technical engineers and developers and product managers. IBM’s design transformation is told... View Details
Keywords: Business Ventures; Business Divisions; Business Units; Business Organization; Change; Change Management; Transformation; Competency and Skills; Talent and Talent Management; Design; Human Resources; Recruitment; Selection and Staffing; Innovation and Invention; Collaborative Innovation and Invention; Innovation and Management; Innovation Strategy; Jobs and Positions; Job Design and Levels; Leading Change; Management; Business or Company Management; Goals and Objectives; Management Practices and Processes; Operations; Product; Product Design; Product Development; Organizations; Business Processes; Organizational Change and Adaptation; Organizational Design; Organizational Structure; Strategy; Adaptation; Adoption; Technological Innovation; Information Infrastructure; Information Technology; Technology Industry; Information Technology Industry; United States
Datar, Srikant M., Amram Migdal, and Paul Hamilton. "IBM: Design Thinking." Harvard Business School Case 121-007, April 2021. (Revised June 2021.)
- November 2017
- Case
BeiGene
By: Willy Shih and Jimmy Zhang
BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window... View Details
Keywords: Biotechnology; Pharmaceutical Company; Pharmaceuticals; China; Regulatory Environment; Business Strategy; Business Startups; Innovation Strategy; Situation or Environment; Pharmaceutical Industry; China
Shih, Willy, and Jimmy Zhang. "BeiGene." Harvard Business School Case 618-033, November 2017.
- 22 Mar 2011
- Working Paper Summaries
Platform Competition under Asymmetric Information
- May 2010 (Revised June 2012)
- Case
From Imitation to Innovation: Zongshen Industrial Group
By: Willy Shih and Nancy Hua Dai
As Zuo Zongshen drove the transformation of the Zongshen Industrial Group from an early imitator in the motorcycle business to a company that increasingly focused on innovation as a way to get out of the hyper-competitive commodity business, he continually faced new... View Details
Keywords: Experience and Expertise; Learning; Investment; Disruptive Innovation; Knowledge Acquisition; Organizational Change and Adaptation; Organizational Structure; Competitive Strategy; Manufacturing Industry; Motorcycle Industry; China
Shih, Willy, and Nancy Hua Dai. "From Imitation to Innovation: Zongshen Industrial Group." Harvard Business School Case 610-057, May 2010. (Revised June 2012.)
- 10 Jan 2017
- First Look
First Look at New Research: January 10, 2017
innovation has gained currency among managers even while core concepts remain misunderstood. Likewise, foundational research on disruption has produced extensive citations and provoked vibrant debates, but... View Details
Keywords: Sean Silverthorne
- 04 Apr 2011
- HBS Case
Reinventing the National Geographic Society
emerging. Various units operated as independent fiefdoms. In 1998, Fahey was named CEO, and the task was clear: build an organization to thrive for the next 100 years. To do so, he "assembled a... View Details
- 05 Sep 2006
- First Look
First Look: September 5, 2006
and scientists has caused the extended social networks of inventors to become increasingly connected. As a result, invention increasingly occurs within small worlds (or social networks) that straddle firm... View Details
Keywords: Sean Silverthorne
- January 2010 (Revised March 2010)
- Case
Transforming ASUSTeK: Breaking from the Past
By: Willy C. Shih, Ho Howard Yu and Hung-Chang Chiu
What happens when an original design manufacturer (ODM) firm tries to transform itself into a branded goods seller? The case traces the evolution of ASUSTeK from a motherboard supplier, to an ODM of desktop and notebook PCs, through its split into three companies that... View Details
Keywords: Change Management; Transformation; Disruptive Innovation; Brands and Branding; Organizational Change and Adaptation; Organizational Structure; Competitive Strategy; Computer Industry; Manufacturing Industry; Taiwan
Shih, Willy C., Ho Howard Yu, and Hung-Chang Chiu. "Transforming ASUSTeK: Breaking from the Past." Harvard Business School Case 610-041, January 2010. (Revised March 2010.)
- August 2024
- Case
Cristina Ventura: The Career of a Catalyst
By: Linda A. Hill, Allison J. Wigen and Ruth Page
This multimedia case follows the career of Chief Catalyst Officer for the Lane Crawford Joyce Group (LCJG), Cristina Ventura. After beginning her career in luxury in Europe and Asia, Ventura was recruited in 2011 to open Apple’s flagship stores in Hong Kong and South... View Details
Keywords: Innovation Leadership; Innovation Strategy; Technological Innovation; Leadership Style; Leading Change; Entrepreneurship; Luxury; Family Business; Personal Development and Career; Fashion Industry; Retail Industry; Technology Industry; Asia; China; Hong Kong
Hill, Linda A., Allison J. Wigen, and Ruth Page. "Cristina Ventura: The Career of a Catalyst." Harvard Business School Multimedia/Video Case 425-708, August 2024.
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- November 2008 (Revised January 2010)
- Case
Stone Finch, Inc.: Young Division, Old Division
By: Richard G. Hamermesh and Elizabeth Collins
CEO Jim Billings wants to attract energetic, entrepreneurial talent to Stone Finch, Inc., which comprises an older division that fabricates products like piping and tanks for water and wastewater processing plants, and a much newer division that develops biochemical... View Details
Keywords: Organizational Behavior; Human Resource Management; Motivation; Business Growth; Motivation and Incentives; Leadership; Business Subsidiaries; Innovation Strategy; Resource Allocation; Organizational Structure; Organizational Culture; Retention; Operations; Recruitment; Integration; Business Growth and Maturation; Mergers and Acquisitions; Growth and Development Strategy; Manufacturing Industry
Hamermesh, Richard G., and Elizabeth Collins. "Stone Finch, Inc.: Young Division, Old Division." Harvard Business School Brief Case 083-214, November 2008. (Revised January 2010.)
- 2007
- Other Unpublished Work
Implementing Technology
By: Diego Comin and Bart Hobijn
We introduce a tractable model of endogenous growth in which the returns to innovation are determined by the technology adoption decisions of the users of new technologies. Technology adoption involves an implementation investment that determines the initial... View Details
Keywords: Learning; Investment; Investment Return; Innovation and Invention; Growth and Development Strategy; Performance Productivity; Technology Adoption
Comin, Diego, and Bart Hobijn. "Implementing Technology." November 2007. (Revise and resubmit at the Journal of Economic Theory.)
- February 2025
- Case
Luca de Meo at Renault Group (A)
By: Emily Truelove, Linda A. Hill and Lydia Begag
When Luca de Meo became CEO of Renault Group in 2020, the 122-year-old French automaker faced financial challenges and the double technological disruption of the automotive industry: the shift to electric vehicles (EVs) and the rise of software-defined vehicles (SDVs).... View Details
Keywords: Change Management; Transformation; Transition; Interpersonal Communication; Forms of Communication; Talent and Talent Management; Experience and Expertise; Customer Value and Value Chain; Decision Making; Economic Growth; Financial Crisis; Alternative Energy; Engineering; Global Strategy; Governance; Digital Transformation; Digital Strategy; Technology Adoption; Disruptive Innovation; Technological Innovation; Innovation Leadership; Collaborative Innovation and Invention; Leading Change; Leadership Development; Leadership Style; Crisis Management; Management Skills; Business Processes; Organizational Culture; Organizational Structure; Performance Efficiency; Transportation; Auto Industry; Battery Industry; Energy Industry; Green Technology Industry; Transportation Industry; France; Europe; China
Truelove, Emily, Linda A. Hill, and Lydia Begag. "Luca de Meo at Renault Group (A)." Harvard Business School Case 425-041, February 2025.
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of... View Details
Keywords: COVID-19; High-risk Patients; Primary Care; Health Pandemics; Health Care and Treatment; Innovation and Invention; Demographics; Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).